arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

PDS Biotechnology Corporation

PDSB Health Care Biotechnology: Pharmaceutical Preparations
$1.08
▼ -12.5% Today
as of Oct 23, 13:05 ET
Last 30 days +174.44% Sep 14 → Oct 23
$0.30 $0.65 $1.00 $1.35 $1.70 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.16
High
$1.22
Low
$1.12
Volume
$5M
Avg Vol
$7M
Mkt Cap
$51M
P/E (TTM)
—
Beta
—
52w High
$1.79
52w Low
$0.20
Div Yield
—
Shares Out
$56M

Recent Press Releases & News last 60 days · 10 items

Oct 20 · 12:00 PR GlobeNewswire
PDS Biotechnology Appoints Three Accomplished Pharma Industry Executives to Board of Directors
Oct 16 · 01:02 MarketBeat
PDS Biotechnology Targets Phase III Trial for PDS0301 in Metastatic Colorectal Cancer
Oct 14 · 15:00 Zacks
PDS Biotechnology (PDSB) Upgraded to Buy: What Does It Mean for the Stock?
▸ Show all 10 press releases & news Free account →

PDSB earnings at a glance

The options market is pricing a move of about ±18.9% after the report, a range of roughly $0.88 to $1.28 from today's $1.08. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±12.0% on average; after the most recent report on May 13, 2026 it moved +20.9%. That means options currently expect more movement than PDSB has typically delivered. PDSB beat the consensus EPS estimate in 4 of its last 4 reported quarters. Implied volatility is currently 320%. The share price of $1.08 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.20
$1.79
55% of range
Avg surprise (last 4)
+12.8%
Avg reaction (last 2)
+12.0%
100% positive
Latest IV / EM
320%
EM ±18.9% · $1 · Oct 9

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.37$-0.31$-0.25$-0.19$-0.13 Actual $-0.32Actual $-0.37Actual $-0.35Actual $-0.30Actual $-0.23Actual $-0.29Actual $-0.21Est $-0.25Actual $-0.21Est $-0.24Actual $-0.19Est $-0.21Actual $-0.13Est $-0.15Actual $-0.18 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-10M$-9M$-9M$-8M$-8M Mar 25Jun 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.18 — — — — financials
Wed May 13, 2026Mar/2026 $-0.13 $-0.15 +13.3% +38.1% +20.9% earnings
Thu Nov 13, 2025Sep/2025 $-0.19 $-0.21 +9.5% — — earnings
Wed Aug 13, 2025Jun/2025 $-0.21 $-0.24 +12.5% — — earnings
Wed May 14, 2025Mar/2025 $-0.21 $-0.25 +16.0% — +3.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.29 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.23 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.30 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.35 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.37 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.32 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-6M$-7M—$-8M$-8M$-9M—$-10M
Net income$-10M$-7M——$-9M$-8M——
EPS (diluted)$-0.18$-0.13—$-0.19$-0.21$-0.21—$-0.29

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$6M$22M$27M$26M$32M$40M$42M$50M
Inventory————————
Total current assets$7M$23M$28M$28M$34M$42M$45M$52M
Total assets$9M$25M$30M$35M$40M$47M$45M$52M
Long-term debt————————
Total liabilities$12M$21M$21M$25M$25M$25M$26M$30M
Total equity$-4M$4M$9M—$16M$22M$19M—

Implied volatility — last 90 days

212%20400%40588%60775%80963% Jun 09 — IV 1666% · EM ±208.7%Jun 10 — IV 1736% · EM ±205.1%Jun 22 — IV 1523% · EM ±317.9%Jun 23 — IV 1654% · EM ±338.3%Jul 01 — IV 2035% · EM ±340.0%Jul 08 — IV 2225% · EM ±278.8%Jul 09 — IV 4839% · EM ±571.6%Jul 10 — IV 2920% · EM ±322.6%Jul 21 — IV 2009% · EM ±467.2%Jul 24 — IV 1660% · EM ±366.9%Jul 27 — IV 3457% · EM ±721.8%Jul 28 — IV 3606% · EM ±737.8%Jul 29 — IV 3880% · EM ±777.1%Jul 30 — IV 3652% · EM ±715.3%Jul 31 — IV 3884% · EM ±743.3%Aug 03 — IV 4029% · EM ±713.9%Aug 05 — IV 4201% · EM ±701.9%Aug 06 — IV 4138% · EM ±669.3%Aug 07 — IV 2765% · EM ±432.1%Aug 10 — IV 4937% · EM ±683.9%Aug 12 — IV 20656% · EM ±2588.0%Aug 13 — IV 24993% · EM ±2952.3%Aug 14 — IV 28294% · EM ±3126.4%Aug 17 — IV 37530% · EM ±3134.7%Aug 18 — IV 30905% · EM ±2235.6%Aug 19 — IV 39228% · EM ±2316.9%Aug 20 — IV 80964% · EM ±3381.3%Aug 24 — IV 10713% · EM ±2237.1%Aug 25 — IV 10540% · EM ±2156.5%Aug 26 — IV 6634% · EM ±1328.8%Aug 27 — IV 10145% · EM ±1987.2%Aug 28 — IV 10530% · EM ±2015.2%Aug 31 — IV 13055% · EM ±2313.1%Sep 01 — IV 11168% · EM ±1923.1%Sep 02 — IV 11696% · EM ±1953.9%Sep 04 — IV 1913% · EM ±299.0%Sep 07 — IV 2133% · EM ±295.5%Sep 08 — IV 1160% · EM ±153.2%Sep 09 — IV 1120% · EM ±140.4%Sep 10 — IV 1091% · EM ±128.9%Sep 14 — IV 601% · EM ±50.2%Sep 15 — IV 601% · EM ±43.5%Sep 16 — IV 476% · EM ±28.1%Sep 17 — IV 832% · EM ±34.8%Sep 21 — IV 245% · EM ±51.2%Sep 22 — IV 213% · EM ±43.5%Sep 23 — IV 255% · EM ±51.2%Sep 24 — IV 549% · EM ±137.5%Sep 25 — IV 559% · EM ±138.0%Oct 06 — IV 403% · EM ±29.1%Oct 07 — IV 320% · EM ±18.9%

Sector peers

DOMH
Dominari Holdings Inc.
$51M $1.77-8.2%
ELTX
Elicio Therapeutics, Inc.
$50M $1.93+15.6%
SER
Serina Therapeutics, Inc.
$50M $1.73-2.3%
CRVO
CervoMed Inc.
$48M $2.28-2.6%
FLNA
Filana Therapeutics, Inc.
$47M $0.65-2.2%
EDSA
Edesa Biotech, Inc.
$46M $2.70-5.3%

PDSB earnings FAQ

What is PDSB's expected move for earnings?

Options currently price a move of about ±18.9%, or $0.20 per share either way from $1.08.

How does PDSB stock usually react to earnings?

Across the last 2 reports the average next-day move was ±12.0%, up 2 times and down 0 times.

What is PDSB's implied volatility?

PDSB's at-the-money implied volatility is about 320% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in